Prevalence and determinants of elevated apolipoprotein B and dense low-density lipoprotein in youths with type 1 and type 2 diabetes

Journal of Clinical Endocrinology and Metabolism

Volumn 93, Issue 3, 2008, Pages 735-742

  Albers, John J ^a   Marcovina, Santica M ^a,j   Imperatore, Giuseppina ^b   Snively, Beverly M ^c   Stafford, Jeanette ^c   Fujimoto, Wilfred Y ^d   Mayer Davis, Elizabeth J ^e   Petitti, Diana B ^f   Pihoker, Catherine ^g   Dolan, Larry ^h   Dabelea, Dana M ⁱ  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b NATIONAL CENTER FOR CHRONIC DISEASE PREVENTION AND HEALTH PROMOTION   (United States)

^c WAKE FOREST SCHOOL OF MEDICINE   (United States)

^d PACIFIC HEALTH RESEARCH INSTITUTE   (United States)

^e UNIVERSITY OF SOUTH CAROLINA   (United States)

^f UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^g SEATTLE CHILDREN S RESEARCH INSTITUTE   (United States)

^h CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

ⁱ UNIVERSITY OF COLORADO   (United States)

^j UNIVERSITY OF WASHINGTON   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN B; HEMOGLOBIN A1C; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADOLESCENT; ADULT; ARTICLE; CLINICAL STUDY; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; FEMALE; GLYCEMIC CONTROL; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; LIPOPROTEIN DEFICIENCY; MALE; MULTIPLE LINEAR REGRESSION ANALYSIS; NON INSULIN DEPENDENT DIABETES MELLITUS; PREVALENCE; PRIORITY JOURNAL; PROTEIN DETERMINATION; RISK FACTOR; SCHOOL CHILD; SYSTOLIC BLOOD PRESSURE;

EID: 40849113050     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2007-2176     Document Type: Article

References (38)

1. Libby P, Nathan DM, Abraham K, Brunzell JD, Fradkin JE, Haffner SM, Hsueh W, Rewers M, Roberts BT, Savage PJ, Skarlatos S, Wassef M, Rabadan-Diehl C 2005 Report of the National Heart, Lung, and Blood Institute-National Institute of Diabetes and Digestive and Kidney Diseases Working Group on Cardiovascular Complications of Type 1 Diabetes Mellitus. Circulation 111:3489-3493
2. Krolewski AS, Kosinski EJ, Warram JH, Leland OS, Busick EJ, Asmal AC, Rand LI, Christlieb AR, Bradley RF, Kahn CR 1987 Magnitude and determinants of coronary artery disease in juvenile-onset, insulin-dependent diabetes mellitus. Am J Cardiol 59:750-755
3. Laakso M 2001 Cardiovascular disease in type 2 diabetes: challenge for treatment and prevention. J Intern Med 249:391-393
4. McGill Jr HC, McMahan CA, Zieske AW, Sloop GD, Walcott JV, Troxclair DA, Malcom GT, Tracy RE, Oalmann MC, Strong JP 2000 Associations of coronary heart disease risk factors with the intermediate lesion of atherosclerosis in youth. The Pathobiological Determinants of Atherosclerosis in Youth (PDAY) Research Group. Arterioscler Thromb Vasc Biol 20:1998-2004
5. Järvisalo MJ, Putto-Laurila A, Jartti L, Lehtimäki T, Solakivi T, Rönnemaa T, Raitakari OT 2002 Carotid artery intima-media thickness in children with type 1 diabetes. Diabetes 51:493-498
6. Krantz JS, Mack WJ, Hodis HN, Liu CR, Liu CH, Kaufman FR 2004 Early onset of subclinical atherosclerosis in young persons with type 1 diabetes. J Pediatrics 145:452-457
7. McMahan CA, Gidding SS, Fayad ZA, Zieske AW, Malcom GT, Tracy RE, Strong JP, McGill Jr HC 2005 Risk scores predict atherosclerotic lesions in young people. Arch Intern Med 165:883-890
8. Austin MA, Edwards KL 1996 Small, dense low density lipoproteins, the insulin resistance syndrome and noninsulin-dependent diabetes. Curr Opin Lipidol 7:167-171
9. Howard BV 1987 Lipoprotein metabolism in diabetes mellitus. J Lipid Res 28:613-628
10. Sniderman AD, Lamarche B, Tilley J, Seccombe D, Frolich J 2002 Hypertriglyceridemic hyperapoB in type 2 diabetes. Diabetes Care 25:579-582
11. Taskinen MR 1990 Hyperlipidaemia in diabetes. Baillieres Clin Endocrinol Metab 4:743-775
12. Taskinen MR 1992 Quantitative and qualitative lipoprotein abnormalities in diabetes mellitus. Diabetes 41(Suppl 2):12-17
13. Rodriguez BL, Fujimoto WY, Mayer-Davis EJ, Imperatore G, Williams DE, Bell RA, Wadwa RP, Palla SL, Liu LL, Kershnar A, Daniels SR, Linder B 2006 Prevalence of cardiovascular disease risk factors in U.S. children and adolescents with diabetes: the SEARCH for Diabetes in Youth study. Diabetes Care 29:1891-1896
14. SEARCH Study Group 2004 SEARCH for Diabetes in Youth: a multicenter study of the prevalence, incidence and classification of diabetes mellitus in youth. Control Clin Trials 25:458-471
15. Warnick GR, Nguyen T, Bergelin RO, Wahl PW, Albers JJ 1982 Lipoprotein quantification: an electrophoretic method compared with the Lipid Research Clinics method. Clin Chem 28:2116-2120
16. Marcovina SM, Albers JJ, Kennedy H, Mei JV, Henderson LO, Hannon WH 1994 International Federation of Clinical Chemistry standardization project for measurements of apolipoproteins A-I and B. IV. Comparability of apolipoprotein B values by use of International Reference Material. Clin Chem 40:586-592
17. Purnell JQ, Marcovina SM, Hokanson JE, Kennedy H, Cleary PA, Steffes MW, Brunzell JD 1995 Levels of lipoprotein(a), apolipoprotein B, and lipoprotein cholesterol distribution in IDDM. Results from follow-up in the Diabetes Control and Complications Trial. Diabetes 44:1218-1226
18. Auwerx JH, Marzetta CA, Hokanson JE, Brunzell JD 1989 Large buoyant LDL-like particles in hepatic lipase deficiency. Arteriosclerosis 9:319-325
19. Marcovina SM, Albers JJ, Gabel B, Koschinsky ML, Gaur VP 1995 Effect of the number of apolipoprotein(a) kringle 4 domains on immunochemical measurements of lipoprotein(a). Clin Chem 41:246-255
20. Albers JJ, Cabana VG, Warnick GR, Hazzard WR 1975 Lp(a) lipoprotein: relationship to sinking pre-β lipoprotein hyperlipoproteinemia, and apolipoprotein B. Metabolism 24:1047-1054
21. Albers JJ, Kennedy H, Marcovina SM 1995 Evidence that Lp(a) contains one molecule of apo(a) and one molecule of apo B: evaluation of amino acid analysis data. J Lipid Res 37:192-196
22. National Cholesterol Education Program (NCEP) Expert Panel 2002 Third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). NIH publication no. 02-5215. Bethesda, MD: National Institutes of Health
23. Contois JH, McNamara JR, Lammi-Keefe CJ, Wilson PW, Massov T, Schaefer EJ 1996 Reference intervals for plasma apolipoprotein B determined with a standardized commercial immunoturbidimetric assay: results from the Framingham Offspring Study. Clin Chem 42:515-523
24. Wagner AM, Perez A, Calvo F, Bonet R, Castellvi A, Ordonez J 1999 Apolipoprotein(B) identifies dyslipidemic phenotypes associated with cardiovascular risk in normocholesterolemic type 2 diabetic patients. Diabetes Care 22:812-817
25. Feingold KR, Grunfeld C, Pang M, Doerrier W, Krauss RM 1992 LDL subclass phenotypes and triglyceride metabolism in non-insulin-dependent diabetes. Arterioscler Thromb 12:1496-1502
26. Walldius G, Jungner I, Holme I, Aastveit AH, Kolar W, Steiner E 2001 High apolipoprotein B, low apolipoprotein A-I, and improvement in the prediction of fatal myocardial infarction (AMORIS study): a prospective study. Lancet 358:2026-2033
27. Pischon T, Girman CJ, Sacks FM, Rifai N, Stampfer MJ, Rimm EB 2005 Non-high-density lipoprotein cholesterol and apolipoprotein B in the prediction of coronary heart disease in men. Circulation 112:3375-3383
28. St. Pierre AC, Cantin B, Dagenais GR, Mauriège P, Bernard PM, Després JP, Lamarche B 2005 Low-density lipoprotein subfractions and the long-term risk of ischemic heart disease in men: 13-year follow-up data from the Quebec Cardiovascular Study. Arterioscler Thromb Vasc Biol 25:553-559
29. Watts GF, Mandalia S, Brunt JN, Slavin BM, Coltart DJ, Lewis B 1993 Independent associations between plasma lipoprotein subfraction levels and the course of coronary artery disease in the St. Thomas' Atherosclerosis Regression Study (STARS). Metabolism 42:1461-1467
30. Rosenson RS, Otvos JD, Freedman DS 2002 Relations of lipoprotein subclass levels and low-density lipoprotein size to progression of coronary artery disease in the Pravastatin Limitation of Atherosclerosis in the Coronary Arteries (PLAC-I) trial. Am J Cardiol 90:89-94
31. Williams PT, Superko HR, Haskell WL, Alderman EL, Blanche PJ, Holl LG, Krauss RM 2003 Smallest LDL particles are most strongly related to coronary disease progression in men. Arterioscler Thromb Vasc Biol 23:314-321
32. Petitti DB, Imperatore G, Palla SL, Daniels SR, Dolan LM, Kershnar AK, Marcovina S, Pettitt DJ, Pihoker C; SEARCH for Diabetes in Youth Study Group 2007 Serum lipids and glucose control: the SEARCH for Diabetes in Youth Study. Arch Ped Adolescent Med 161:159-165
33. Sibley SD, Thomas W, de Boer I, Brunzell JD, Steffes MW 2006 Gender and elevated albumin excretion in the Diabetes Control and Complications Trial/ Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) cohort: role of central obesity. Am J Kidney Dis 47:223-232
34. Purnell JQ, Hokanson JE, Marcovina SM, Steffes MW, Cleary PA, Brunzell JD 1998 Effect of excessive weight gain with intensive therapy of type 1 diabetes on lipid levels and blood pressure: results from the DCCT. Diabetes Control and Complications Trial. JAMA [Erratum (1998) 280:1484] 280:140-146
35. Taskinen MR, Kuusi T, Helve E, Nikkila EA, Yki-Jarvinen H 1988 Insulin therapy induces antiatherogenic changes of serum lipoproteins in noninsulin-dependent diabetes. Arteriosclerosis 8:168-177
36. American Diabetes Association 2000 Type 2 diabetes in children and adolescents. Diabetes Care 23:381-389
37. American Diabetes Association 2003 Management of dyslipidemia in children and adolescents with diabetes. Diabetes Care 26:2194-2197
38. Kavey REW, Daniels SR, Lauer RM, Atkins DL, Hayman LL, Tanbertk 2003 American Heart Association guidelines for primary prevention of atherosclerotic cardiovascular disease beginning in childhood. Circulation 107:1562-1566